Viewing StudyNCT02216890

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:09 AM
Last Modification Date: 2024-10-26 @ 11:29 AM
Study NCT ID: NCT02216890
Status: COMPLETED
Last Update Posted: 2018-04-19
First Post: 2014-08-12
Brief Title: Safety Study of SGN-CD70A in Cancer Patients
Sponsor: Seagen Inc
Organization: Seagen Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Follicular Lymphoma Grade 3
Renal Cell Carcinoma
Mantle-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Keywords:
Name View
Drug Therapy View
Renal Cell Carcinoma View
Mantle-Cell Lymphoma View
Diffuse Large B-Cell Lymphoma View
Follicular Lymphoma Grade 3 View
Antibody-Drug Conjugate View
CD70 Antigen View